VISTA and its ligands: the next generation of promising therapeutic targets in immunotherapy

V-domain immunoglobulin suppressor of T cell activation (VISTA) is a novel negative checkpoint receptor (NCR) primarily involved in maintaining immune tolerance. It has a role in the pathogenesis of autoimmune disorders and cancer and has shown promising results as a therapeutic target. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Shekari, Najibeh, Shanehbandi, Dariush, Kazemi, Tohid, Zarredar, Habib, Baradaran, Behzad, Jalali, Seyed Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631023/
https://www.ncbi.nlm.nih.gov/pubmed/37936192
http://dx.doi.org/10.1186/s12935-023-03116-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631023/
https://www.ncbi.nlm.nih.gov/pubmed/37936192
http://dx.doi.org/10.1186/s12935-023-03116-0

Ejemplares similares